Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Catherine Obrien

Concepts (151)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cystic Fibrosis
12
2021
151
3.020
Why?
Students, Pharmacy
5
2019
124
1.480
Why?
Patient-Centered Care
2
2019
129
1.140
Why?
Education, Pharmacy
5
2019
146
0.990
Why?
Professional-Patient Relations
3
2019
48
0.910
Why?
Schools, Pharmacy
3
2019
53
0.820
Why?
Alprostadil
2
2011
10
0.730
Why?
Educational Measurement
5
2019
205
0.720
Why?
Constipation
2
2011
33
0.710
Why?
Pharmacists
2
2019
145
0.620
Why?
Curriculum
7
2019
398
0.590
Why?
Radius
1
2018
27
0.580
Why?
Neutrophils
2
2015
148
0.510
Why?
Respiratory System
1
2015
27
0.510
Why?
Respiratory Tract Infections
1
2015
76
0.480
Why?
Tracheostomy
1
2015
71
0.480
Why?
Dietary Supplements
2
2012
445
0.470
Why?
Health Knowledge, Attitudes, Practice
2
2016
490
0.450
Why?
Gastric Acid
1
2013
9
0.440
Why?
Enterocolitis, Pseudomembranous
1
2013
24
0.430
Why?
Dietetics
1
2012
11
0.420
Why?
Nutrition Therapy
1
2012
20
0.420
Why?
Lymphocytes
1
2013
154
0.410
Why?
Lung
2
2013
512
0.410
Why?
Tomography, X-Ray Computed
1
2018
1160
0.400
Why?
Enteral Nutrition
1
2012
149
0.390
Why?
Motivational Interviewing
2
2019
32
0.320
Why?
Cesium
1
2008
8
0.310
Why?
Pharmaceutical Services
2
2019
52
0.310
Why?
Chlorides
1
2008
50
0.310
Why?
Humans
23
2021
50389
0.300
Why?
Problem-Based Learning
1
2008
47
0.290
Why?
Pseudomonas Infections
2
2019
50
0.290
Why?
Pseudomonas aeruginosa
2
2019
74
0.290
Why?
Education, Medical, Undergraduate
1
2008
83
0.290
Why?
Pilot Projects
4
2018
704
0.280
Why?
Electrocardiography
1
2008
267
0.270
Why?
Students, Medical
1
2008
159
0.260
Why?
Child
7
2018
6877
0.250
Why?
Depression
2
2021
572
0.240
Why?
Adolescent
7
2015
6475
0.230
Why?
Female
13
2019
26981
0.230
Why?
Male
12
2019
25718
0.220
Why?
Infant
4
2015
3601
0.210
Why?
Anti-Bacterial Agents
2
2019
745
0.200
Why?
Vitamin D Deficiency
1
2012
44
0.190
Why?
Vitamin D
1
2012
88
0.190
Why?
College Admission Test
2
2018
13
0.190
Why?
School Admission Criteria
2
2018
35
0.180
Why?
Chloride Channels
2
2011
26
0.180
Why?
Forced Expiratory Volume
3
2019
44
0.180
Why?
Off-Label Use
1
2019
26
0.170
Why?
Pneumonia, Bacterial
1
2019
27
0.170
Why?
Airway Management
1
2019
19
0.160
Why?
Mass Screening
1
2012
348
0.160
Why?
Self Efficacy
1
2019
130
0.150
Why?
Patient Compliance
1
2019
231
0.140
Why?
Communication
1
2019
246
0.140
Why?
Retrospective Studies
4
2018
6223
0.140
Why?
Absorptiometry, Photon
1
2018
155
0.140
Why?
Case-Control Studies
2
2018
1148
0.140
Why?
Adult
8
2021
13568
0.140
Why?
Health Behavior
1
2019
251
0.140
Why?
Education, Pharmacy, Graduate
1
2016
19
0.130
Why?
Young Adult
4
2018
4064
0.130
Why?
Drug Repositioning
1
2015
11
0.130
Why?
Bone Density
1
2018
385
0.130
Why?
Fenofibrate
1
2015
16
0.120
Why?
Methicillin-Resistant Staphylococcus aureus
1
2015
77
0.120
Why?
Quinolines
1
2015
41
0.120
Why?
Acetates
1
2015
49
0.120
Why?
Megacolon, Toxic
1
2013
3
0.110
Why?
Epithelial Cells
1
2015
210
0.110
Why?
Antacids
1
2013
11
0.110
Why?
Leukocyte Count
1
2013
72
0.110
Why?
Colon
1
2013
96
0.110
Why?
Appetite Stimulants
1
2012
5
0.110
Why?
Fatal Outcome
1
2013
195
0.100
Why?
Enzymes
1
2012
30
0.100
Why?
Proton Pump Inhibitors
1
2013
85
0.100
Why?
Staphylococcal Infections
1
2015
269
0.100
Why?
Cross-Sectional Studies
1
2018
1590
0.100
Why?
Gastrostomy
1
2012
56
0.100
Why?
Zinc
1
2012
53
0.100
Why?
Health Care Surveys
1
2012
173
0.100
Why?
Dietary Fats
1
2012
126
0.100
Why?
Bone Diseases
1
2012
97
0.100
Why?
Biopsy
1
2013
592
0.090
Why?
Body Composition
1
2013
326
0.090
Why?
Asthma
1
2015
282
0.090
Why?
Inflammation
1
2015
608
0.090
Why?
Diet, High-Fat
1
2012
214
0.090
Why?
Internet
1
2012
261
0.090
Why?
Body Mass Index
1
2013
669
0.090
Why?
Mental Disorders
1
2015
404
0.090
Why?
Treatment Outcome
2
2011
5230
0.090
Why?
Secondary Prevention
1
2010
79
0.080
Why?
Cystic Fibrosis Transmembrane Conductance Regulator
1
2010
36
0.080
Why?
Intestinal Obstruction
1
2010
36
0.080
Why?
Coronary Artery Disease
1
2012
277
0.080
Why?
Biphenyl Compounds
1
2008
31
0.080
Why?
Adaptation, Psychological
2
2021
226
0.080
Why?
Angiotensin II Type 1 Receptor Blockers
1
2008
43
0.080
Why?
Infant, Newborn
1
2015
2780
0.080
Why?
Tetrazoles
1
2008
40
0.080
Why?
Self-Assessment
1
2008
44
0.080
Why?
Benzimidazoles
1
2008
49
0.080
Why?
Peer Group
1
2008
54
0.070
Why?
Longitudinal Studies
2
2021
709
0.070
Why?
Program Development
1
2008
162
0.070
Why?
Child, Preschool
1
2015
3908
0.070
Why?
Program Evaluation
1
2008
349
0.070
Why?
Carcinoma, Hepatocellular
1
2008
196
0.060
Why?
Blood Pressure
1
2008
529
0.060
Why?
Clinical Competence
1
2008
397
0.060
Why?
Risk Factors
1
2013
3692
0.060
Why?
Liver Neoplasms
1
2008
331
0.060
Why?
Hypertension
1
2008
550
0.050
Why?
Logistic Models
2
2016
900
0.050
Why?
Ergocalciferols
1
2012
1
0.050
Why?
25-Hydroxyvitamin D 2
1
2012
2
0.050
Why?
Calcifediol
1
2012
8
0.050
Why?
Malabsorption Syndromes
1
2012
9
0.050
Why?
Cholecalciferol
1
2012
22
0.050
Why?
Seasons
1
2012
81
0.050
Why?
Evidence-Based Practice
1
2012
98
0.050
Why?
Spirituality
1
2021
30
0.050
Why?
Administration, Inhalation
1
2019
111
0.040
Why?
Respiratory Function Tests
1
2019
88
0.040
Why?
Dose-Response Relationship, Drug
2
2015
1356
0.040
Why?
Age Factors
1
2012
1104
0.040
Why?
Middle Aged
3
2019
12460
0.040
Why?
Pharmacy
1
2018
54
0.040
Why?
Social Support
1
2019
263
0.040
Why?
Universities
1
2018
170
0.040
Why?
Anxiety
1
2019
278
0.030
Why?
Disease Progression
1
2019
823
0.030
Why?
Chemokine CXCL5
1
2015
5
0.030
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2015
54
0.030
Why?
Bronchi
1
2015
44
0.030
Why?
Granulocyte Colony-Stimulating Factor
1
2015
60
0.030
Why?
Chemokines
1
2015
76
0.030
Why?
Interleukin-8
1
2015
86
0.030
Why?
Sulfides
1
2015
28
0.030
Why?
Cyclopropanes
1
2015
24
0.030
Why?
Anti-Asthmatic Agents
1
2015
29
0.030
Why?
Tumor Necrosis Factor-alpha
1
2015
388
0.030
Why?
Cells, Cultured
1
2015
1589
0.020
Why?
Gene Expression Profiling
1
2015
1029
0.020
Why?
Blood Pressure Monitoring, Ambulatory
1
2008
36
0.020
Why?
United States
1
2019
4913
0.020
Why?
Obrien's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description